4 Einträge gefunden

1. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial

   1. Döhner, Hartmut
   2. Weber, Daniela
   3. Krzykalla, Julia
   4. Fiedler, Walter
   5. Kühn, Michael W M
   6. Schroeder, Thomas
   7. Mayer, Karin

   2023 - Forschungsinformationssystem des UKE
2. Midostaurin plus intensive chemotherapy for younger and older Patients with AML and FLT3 internal tandem duplications

   1. Döhner, Hartmut
   2. Weber, Daniela
   3. Krzykalla, Julia
   4. Fiedler, Walter
   5. Wulf, Gerald Georg
   6. Salih, Helmut R
   7. Lübbert, Michael

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

   1. Döhner, Hartmut
   2. Müller-Tidow, Carsten
   3. Lübbert, Michael
   4. Fiedler, Walter
   5. Krämer, Alwin
   6. Westermann, Jörg
   7. Bug, Gesine

   2019 - Forschungsinformationssystem des UKE
4. Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

   1. Döhner, Hartmut
   2. Lübbert, Michael
   3. Fiedler, Walter
   4. Fouillard, Loic
   5. Haaland, Alf
   6. Brandwein, Joseph M
   7. Lepretre, Stephane

   2014 - Forschungsinformationssystem des UKE